Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» The Rivaroxaban (Xarelto) FDA Panel and Large Pragmatic Trials
The Rivaroxaban (Xarelto) FDA Panel and Large Pragmatic Trials
The Rivaroxaban (Xarelto) FDA Panel and Large Pragmatic Trials
Submitted by
admin
on September 10, 2011 - 10:25am
Source:
Forbes
News Tags:
Xarelto
JNJ
anti-clotting
atrial fibrillation
FDA
Headline:
The Rivaroxaban (Xarelto) FDA Panel and Large Pragmatic Trials
Do Not Allow Advertisers to Use My Personal information
